Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Designing Impactful Warnings for Sugary Drinks

22 gennaio 2021 aggiornato da: University of North Carolina, Chapel Hill

The goal of this online RCT study is to examine how sugar-sweetened beverage (SSB) health warnings influence US adults' perceptions and reactions. The investigators have the following predictions:

  1. SSB warnings will be perceived as more effective than the control (message topic)
  2. Icon and graphic warnings will be perceived as more effective than text-only warnings (message type)

The investigators will also examine the interaction of warning topic and warning type, but have no specific hypothesis about this interaction.

Finally, the investigators will test the following predictions about the secondary outcomes:

SSB warnings (vs. control), as well as icon and graphic warnings (vs text.warnings), will lead to lower perceived product healthfulness, lower purchase intentions, and higher cognitive elaboration.

Panoramica dello studio

Descrizione dettagliata

Childhood obesity is a major public health problem in the US among racial and ethnic minorities, including among the US's growing Latino population. One promising but understudied policy for addressing childhood obesity is requiring warnings on the front of sugar-sweetened beverage containers. However, the topic and design of warnings that are most effective in communicating the harms of sugar-sweetened beverages remains unknown. This study assess which warning topics and which warning designs lead to the greatest perceived message effectiveness among US Latino and non-Latino parents of children ages 2-12. The investigators focus on parents as they are the primary decision-makers and purchasers of food products for children and exert strong influence over their children's dietary intake and food attitudes.

Setting: The trial will take place online on a survey developed using Qualtrics.

Recruitment: Participants will be recruited online by CloudResearch PrimePanels, a survey research platform with access to over 20 million participants. As such, participants will have to be PrimePanels members in order to participate.

Informed Consent: After determining eligibility, eligible participants will be directed to a page on Qualtrics with the consent form. Participants acknowledge their consent in the study by clicking the "next page" arrow and proceeding to the study.

Randomization: After consenting, the participant is randomly assigned to to view one of the 5 warning topics. "WARNING: High in added sugar" (added sugar), "WARNING: Excess consumption of drinks with added sugar contributes to weight gain" (weight gain), "WARNING: Excess consumption of drinks with added sugar contributes to type 2 diabetes" (Type 2 diabetes), "WARNING: Excess consumption of drinks with added sugar contributes to heart damage" (heart damage), and "Please refrain from littering" (control). Within each of the four experimental arms, participants see the message displayed on four different types of warning designs: a text warning on a square background, a text warning on a octagon background, and icon warning, and a graphic warning. Within the control arm, participants see the message displayed on three different types of warning designs: a text warning on a square background, an icon warning, and a graphic warning. Participants randomly see the different warning designs in a random order.

Survey: The participants complete a survey answering behavioral perceptions and intentions questions about the different warning labels.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

1078

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • North Carolina
      • Chapel Hill, North Carolina, Stati Uniti, 27599
        • University of North Carolina Chapel Hill

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 99 anni (Adulto, Adulto più anziano)

Accetta volontari sani

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • at least 18 years old
  • Prime Panels member
  • have at least one child ages 2-12
  • Currently reside in the US

Exclusion Criteria:

  • less than 18 years old

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Added sugar warning message
Message displayed on warning labels is: "WARNING: High in added sugar."
The warning message is in white text on a black square background
The warning message is in white text on a black octagon background
The warning message in in white text on a black background, below an icon that conveys the topic the warning is about
The warning message in in white text on a black background, below a graphic that conveys the topic the warning is about
Sperimentale: Weight gain warning message
Message displayed on warning labels is: "WARNING: Excess consumption of drinks with added sugar contributes to weight gain."
The warning message is in white text on a black square background
The warning message is in white text on a black octagon background
The warning message in in white text on a black background, below an icon that conveys the topic the warning is about
The warning message in in white text on a black background, below a graphic that conveys the topic the warning is about
Sperimentale: Type 2 diabetes warning message
Message displayed on warning labels is: "WARNING: Excess consumption of drinks with added sugar contributes to type 2 diabetes."
The warning message is in white text on a black square background
The warning message is in white text on a black octagon background
The warning message in in white text on a black background, below an icon that conveys the topic the warning is about
The warning message in in white text on a black background, below a graphic that conveys the topic the warning is about
Sperimentale: Heart damage warning message
Message displayed on warning labels is: "WARNING: Excess consumption of drinks with added sugar contributes to heart damage."
The warning message is in white text on a black square background
The warning message is in white text on a black octagon background
The warning message in in white text on a black background, below an icon that conveys the topic the warning is about
The warning message in in white text on a black background, below a graphic that conveys the topic the warning is about
Comparatore attivo: Neutral message
Message displayed on control label is: "Please refrain from littering."
The warning message is in white text on a black square background
The warning message in in white text on a black background, below an icon that conveys the topic the warning is about
The warning message in in white text on a black background, below a graphic that conveys the topic the warning is about

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Perceived message effectiveness
Lasso di tempo: During survey, which lasts approximately 12-15 minutes.

Perceived message effectiveness as measured by average response to three statements:

This message makes me concerned about the health effects of drinking beverages with added sugar. Response options are on a scale (1=Strongly disagree...5=Strongly agree).

This message makes drinking beverages with added sugar seem unpleasant to me. Response options are on a scale (1=Strongly disagree...5=Strongly agree).

This message discourages me from wanting to drink beverages with added sugar. Response options are on a scale (1=Strongly disagree...5=Strongly agree).

During survey, which lasts approximately 12-15 minutes.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Perceived product healthfulness of beverages with added sugar
Lasso di tempo: During survey, which lasts approximately 12-15 minutes.
Measured with the question, "How healthy or unhealthy would it be for your child to drink beverages with added sugar every day?" Response options are on a scale (1= Very unhealthy...5=Very healthy).
During survey, which lasts approximately 12-15 minutes.
Intentions to purchase beverages with added sugar
Lasso di tempo: During survey, which lasts approximately 12-15 minutes.
Measured with the question, "How likely are you to buy beverages with added sugar for your child in the next four weeks?" Response options are on a scale (1 = Not at all likely...5 = Extremely likely).
During survey, which lasts approximately 12-15 minutes.
Thinking about the health problems from beverages with added sugar
Lasso di tempo: During survey, which lasts approximately 12-15 minutes.
Measured with the question, "How much does this message make you think about the health problems caused by drinking beverages with added sugar?" Response options are on a scale (1=Not at all...5=Very much).
During survey, which lasts approximately 12-15 minutes.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Marissa G Hall, PhD, University of North Carolina

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

7 ottobre 2019

Completamento primario (Effettivo)

4 novembre 2019

Completamento dello studio (Effettivo)

4 novembre 2019

Date di iscrizione allo studio

Primo inviato

6 maggio 2020

Primo inviato che soddisfa i criteri di controllo qualità

6 maggio 2020

Primo Inserito (Effettivo)

11 maggio 2020

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

25 gennaio 2021

Ultimo aggiornamento inviato che soddisfa i criteri QC

22 gennaio 2021

Ultimo verificato

1 gennaio 2021

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 19-0277a

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Comportamento sanitario

Sottoscrivi